SCHEMBL9350770

SCHEMBL9350770

CNc1cc(=O)n(C2CCCCC2)c(=O)n1C1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.42
TSHR P16473 3/20 0.42
POLB P06746 2/20 0.42
HTT P42858 2/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP2C9 P11712 4/20 0.41
CYP2C19 P33261 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PKM P14618 1/20 0.41
MAPT P10636 1/20 0.40
GSK3A P49840 1/20 0.40
GSK3B P49841 1/20 0.40
CYP3A4 P08684 3/20 0.39
MAPK1 P28482 2/20 0.39
CYP1A2 P05177 1/20 0.39
ALOX15 P16050 2/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
JAK2 O60674 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11430502 0.76 JAK2 (0.46) ALDH1A1TSHRPOLBHTTHSD17B10
SCHEMBL9350668 0.74 ALDH1A1 (0.44) ALDH1A1TSHRPOLBHTTHSD17B10
SCHEMBL4763682 0.72 ALDH1A1 (0.49) ALDH1A1TSHRPOLBHTTHSD17B10
SCHEMBL25827617 0.72 ALDH1A1 (0.41) ALDH1A1TSHRPOLBHTTHSD17B10
SCHEMBL11840108 0.71 JAK2 (0.47) ALDH1A1TSHRPOLBHTTHSD17B10
SCHEMBL11847806 0.71 GSK3A (0.54) ALDH1A1TSHRHTTHSD17B10CYP2C9
SCHEMBL11428167 0.70 GSK3A (0.44) ALDH1A1TSHRPOLBHTTHSD17B10
SCHEMBL11724195 0.70 ALDH1A1 (0.44) ALDH1A1TSHRPOLBHTTHSD17B10
SCHEMBL1419525 0.69 PDE4A (0.43) ALDH1A1HTTMAPTGAAMEN1
SCHEMBL16004440 0.69 GSK3A (0.50) ALDH1A1TSHRCYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1031641-C Process for preparing 8-substituted xanthine BEECHAM WUELFING GMBH & CO KG (DE) 1996-04-24 CN disclosed
EP-0369744-B1 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GMBH (DE) 1994-09-21 EP disclosed
US-5321029-A Vascular and skin disorders; bronchodilator BEECHAM-WUELFING GMBH & CO.K.G. (DE) 1994-06-14 US disclosed
CN-1047502-A The preparation method of 8-substituted xanthine BEECHAM WUELFING GMBH & CO KG (DE) 1990-12-05 CN disclosed
EP-0369744-A2 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GmbH (DE) 1990-05-23 EP disclosed